K 3.1, 2.1
|
|
2fg7C
|
N-succinyl-l-ornithine transcarbamylase from b. fragilis complexed with carbamoyl phosphate and n-succinyl-l-norvaline
|
K 3.1, 2.1
|
|
6km5A
|
Human carbonic anhydrase ii native 13 atm co2
|
K 3.1, 2.1
|
|
6sdtA
|
Human carbonic anhydrase vii in complex with a sulfonamide inhibitor
|
K 3.1, 2.1
|
|
6t9zA
|
Nidocarborane inhibitor of carbonic anhydrase ix
|
K 3.1, 2.1
|
|
6ouhA
|
Carbonic anhydrase ii mimic complexed with benzene sulfonamide mb11-710a
|
K 3.1, 2.1
|
|
6oubA
|
Carbonic anhydrase ii complexed with benzene sulfonamide mb11-694b
|
K 3.1, 2.1
|
|
6r6yA
|
Crystal structure of human carbonic anhydrase isozyme xii with 4-chloro-2-cyclohexylsulfanyl-n-(2-hydroxyethyl)-5-sulfamoyl-benzamide
|
K 3.1, 2.1
|
|
6r71A
|
Crystal structure of human carbonic anhydrase isozyme xii with 2-(benzenesulfonyl)-4-chloro-n-(2-hydroxyethyl)-5-sulfamoyl-benzamide
|
K 3.1, 2.1
|
|
6ugzA
|
Human carbonic anhydrase ix-mimic complexed with sb4-208
|
K 3.1, 2.1
|
|
6ugpA
|
Human carbonic anhydrase 2 complexed with sb4-206
|
K 3.1, 2.1
|
|
6ugrA
|
Human carbonic anhydrase 2 complexed with sb4-208
|
K 3.1, 2.1
|
|
6vkgA
|
Human carbonic anhydrase ix mimic with epacadostat bound
|
K 3.1, 2.1
|
|
6ugnA
|
Human carbonic anhydrase 2 complexed with sb4-205
|
K 3.1, 2.1
|
|
6ugqA
|
Human carbonic anhydrase ix-mimic complexed with sb4-206
|
K 3.1, 2.1
|
|
6ugoA
|
Human carbonic anhydrase ix-mimic complexed with sb4-205
|
K 3.1, 2.1
|
|
6uh0A
|
Human carbonic anhydrase 2 in complex with sb4-202
|
K 3.1, 2.1
|
|
6vj3A
|
Carbonic anhydrase ii in complex with pyrimidine-based inhibitor
|
K 3.1, 2.1
|
|
6peaA
|
High resolution apo carbonic anhydrase ii
|
K 3.1, 2.1
|
|
6r6fA
|
Crystal structure of human carbonic anhydrase isozyme ii with 4-chloro-2-cyclohexylsulfanyl-n-(2-hydroxyethyl)-5-sulfamoyl-benzamide
|
K 3.1, 2.1
|
|
6pdvA
|
Cu-carbonic anhydrase ii, a nitrite reductase
|
K 3.1, 2.1
|
|
6qngA
|
Three dimensional structure of human carbonic anhydrase xii in complex with benzenesulfonamide
|
K 3.1, 2.1
|
|
6qnlA
|
Three dimensional structure of human carbonic anhydrase xii in complex with benzenesulfonamide
|
K 3.1, 2.1
|
|
6qn6A
|
Three dimensional structure of human carbonic anhydrase ix in complex with benzenesulfonamide
|
K 3.1, 2.1
|
|
6qn5A
|
Three dimensional structure of human carbonic anhydrase ix in complex with benzenesulfonamide
|
K 3.1, 2.1
|
|
6qn2A
|
Three dimensional structure of human carbonic anhydrase ix in complex with benzenesulfonamide
|
K 3.1, 2.1
|
|
6qn0A
|
Three dimensional structure of human carbonic anhydrase xii in complex with benzenesulfonamide
|
K 3.1, 2.1
|
|
6u4qA
|
Carbonic anhydrase 2 in complex with sb4197
|
K 3.1, 2.1
|
|
6u4tA
|
Carbonic anhydrase 9 in complex with sb4197
|
K 3.1, 2.1
|
|
6nlvA
|
Selective inhibition of carbonic anhydrase ix activity, using compound slc-149, displays limited anticancer effects in breast cancer cell lines
|
K 3.1, 2.1
|
|
6nm0A
|
Selective inhibition of carbonic anhydrase ix activity, using compound slc-149, displays limited anticancer effects in breast cancer cell lines
|
K 3.1, 2.1
|
|
6i0wA
|
Human carbonic anhydrase ii in complex with 4-methoxybenzenesulfonamide
|
K 3.1, 2.1
|
|
6i1uA
|
Human carbonic anhydrase ii in complex with 4-ethoxybenzenesulfonamide
|
K 3.1, 2.1
|
|
6i2fA
|
Human carbonic anhydrase ii in complex with 4-propoxybenzenesulfonamide
|
K 3.1, 2.1
|
|
6qqmA
|
Crystal structure of the alpha carbonic anhydrase from schistosoma mansoni
|
K 3.1, 2.1
|
|
6hxdA
|
Human carbonic anhydrase ii in complex with 4-butylbenzenesulfonamide
|
K 3.1, 2.1
|
|
6qqrA
|
Crystal structure of trmd, a trna-(n1g37) methyltransferase, from mycobacterium abscessus in complex with inhibitor
|
K 3.1, 2.1
|
|
6qqqA
|
Crystal structure of trmd, a trna-(n1g37) methyltransferase, from mycobacterium abscessus in complex with inhibitor
|
K 3.1, 2.1
|
|
6qreA
|
Crystal structure of trmd, a trna-(n1g37) methyltransferase, from mycobacterium abscessus in complex with inhibitor
|
K 3.1, 2.1
|
|
6qrdA
|
Crystal structure of trmd, a trna-(n1g37) methyltransferase, from mycobacterium abscessus in complex with inhibitor
|
K 3.1, 2.1
|
1
|
6qr3A
|
Crystal structure of trmd, a trna-(n1g37) methyltransferase, from mycobacterium abscessus in complex with inhibitor
|
K 3.1, 2.1
|
|
6qr1A
|
Crystal structure of trmd, a trna-(n1g37) methyltransferase, from mycobacterium abscessus in complex with inhibitor
|
K 3.1, 2.1
|
|
6qrfA
|
Crystal structure of trmd, a trna-(n1g37) methyltransferase, from mycobacterium abscessus in complex with inhibitor
|
K 3.1, 2.1
|
|
6qqvA
|
Crystal structure of trmd, a trna-(n1g37) methyltransferase, from mycobacterium abscessus in complex with inhibitor
|
K 3.1, 2.1
|
|
6qr0A
|
Crystal structure of trmd, a trna-(n1g37) methyltransferase, from mycobacterium abscessus in complex with inhibitor
|
K 3.1, 2.1
|
|
6qr2A
|
Crystal structure of trmd, a trna-(n1g37) methyltransferase, from mycobacterium abscessus in complex with inhibitor
|
K 3.1, 2.1
|
|
6qqtA
|
Crystal structure of trmd, a trna-(n1g37) methyltransferase, from mycobacterium abscessus in complex with inhibitor
|
K 3.1, 2.1
|
|
6qqzA
|
Crystal structure of trmd, a trna-(n1g37) methyltransferase, from mycobacterium abscessus in complex with inhibitor
|
K 3.1, 2.1
|
|
6qqwA
|
Crystal structure of trmd, a trna-(n1g37) methyltransferase, from mycobacterium abscessus in complex with inhibitor
|
K 3.1, 2.1
|
|
6qraA
|
Crystal structure of trmd, a trna-(n1g37) methyltransferase, from mycobacterium abscessus in complex with inhibitor
|
K 3.1, 2.1
|
|
6uevA
|
Structure of unliganded trna (guanine-n1)-methyltransferase found in anaplasma phagocytophilum
|
K 3.1, 2.1
|
|
6ql1A
|
Crystal structure of chimeric carbonic anhydrase vi with 4-[(4,6-dimethylpyrimidin-2-yl)thio]-2,3,5,6-tetrafluorobenzenesulfonamide
|
K 3.1, 2.1
|
2
|
6nj2A
|
Thermostable carbonic anhydrase ii variant with tetrazine 2.0 at site 186
|
K 3.1, 2.1
|
3
|
6nj3A
|
Thermostable variant of human carbonic anhydrase with ordered tetrazine 2.0 at site 233
|
K 3.1, 2.1
|
|
6ql3A
|
Crystal structure of chimeric carbonic anhydrase vi with 3-(cyclooctylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide
|
K 3.1, 2.1
|
|
6ql2A
|
Crystal structure of chimeric carbonic anhydrase vi with ethoxzolamide.
|
K 3.1, 2.1
|
2
|
6nj6A
|
Thermostable variant of human carbonic anhydrase with tetrazine 2.0 at site 186 reacted with stco in crystallo
|
K 3.1, 2.1
|
|
6hr3A
|
Human carbonic anhydrase ii in complex with 4-propylbenzenesulfonamide
|
K 3.1, 2.1
|
2
|
6nj5A
|
Thermostable variant of human carbonic anhydrase ii with disordered tetrazine 2.0 at site 233
|
K 3.1, 2.1
|
3
|
6nj4A
|
Thermostable variant of human carbonic anhydrase with disordered tetrazine 2.0 reacted with strained trans-cyclooctene at site 233
|
K 3.1, 2.1
|
|
6hzxA
|
Protein-aromatic foldamer complex crystal structure
|
K 3.1, 2.1
|
|
6rqnA
|
X-ray crystal structure of protiated (h) small monoclinic unit cell ca ix sv.
|
K 3.1, 2.1
|
|
6rqqA
|
X-ray crystal structure of protiated (h) large monoclinic unit cell ca ix sv.
|
K 3.1, 2.1
|
3
|
6ac6A
|
Ab initio crystal structure of selenomethionine labelled mycobacterium smegmatis mfd
|
K 3.1, 2.1
|
|
6rxtCN
|
Cryo-em structure of the 90s pre-ribosome (kre33-noc4) from chaetomium thermophilum, state a
|
K 3.1, 2.1
|
|
6afkA
|
Crystal structure of trmd from pseudomonas aeruginosa in complex with active-site inhibitor
|
K 3.1, 2.1
|
|
6gdcA
|
Human carbonic anhydrase ii in complex with benzenesulfonamide
|
K 3.1, 2.1
|
|
6g6tA
|
Crystal structure of human carbonic anhydrase isozyme ii with n-butyl-2,4-dichloro-5-sulfamoyl-benzamide
|
K 3.1, 2.1
|
|
6g5uA
|
Crystal structure of human carbonic anhydrase isozyme xiii with n-butyl-2,4-dichloro-5-sulfamoyl-benzamide
|
K 3.1, 2.1
|
|
6gcyA
|
Joint neutron and x-ray crystal structure of human carbonic anhydrase ix mimic (saccharin-sugar conjugate complex)
|
K 3.1, 2.1
|
|
6fjiA
|
Joint neutron and x-ray crystal structure of human carbonic anhydrase ix mimic (apo).
|
K 3.1, 2.1
|
|
6h38A
|
The crystal structure of human carbonic anhydrase vii in complex with 4-[(4-fluorophenyl)methyl]-1-piperazinyl]benzenesulfonamide.
|
K 3.1, 2.1
|
|
6fjjA
|
Joint neutron and x-ray crystal structure of human carbonic anhydrase ix mimic (saccharin).
|
K 3.1, 2.1
|
|
6mbyA
|
Carbonic anhydrase ii in complex with ferulic acid
|
K 3.1, 2.1
|
|
6mbvA
|
Carbonic anhydrase ii in complex with nicotinic acid
|
K 3.1, 2.1
|
|
6g5lA
|
Crystal structure of human carbonic anhydrase isozyme xii with 4-chloro-2-(cyclohexylamino)-n-(2-hydroxyethyl)-5-sulfamoyl-benzamide
|
K 3.1, 2.1
|
|
6g7aA
|
Crystal structure of human carbonic anhydrase isozyme xii 2-(benzylamino)-4-chloro-n-(2-hydroxyethyl)-5-sulfamoyl-benzamide
|
K 3.1, 2.1
|
|
6h6sA
|
Sad phasing on nickel-substituted human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
6h37A
|
The crystal structure of human carbonic anhydrase vii in complex with 4-(4-phenyl)-4-hydroxy-1-piperidine-1-carbonyl)benzenesulfonamide
|
K 3.1, 2.1
|
|
6h36A
|
The crystal structure of human carbonic anhydrase vii in complex with 4-(4-phenylpiperidine-1-carbonyl)benzenesulfonamide.
|
K 3.1, 2.1
|
|
6hwzA
|
Selenols: a new class of carbonic anhydrase inhibitors
|
K 3.1, 2.1
|
|
6hx5A
|
Selenols: a new class of carbonic anhydrase inhibitors
|
K 3.1, 2.1
|
|
6eeaA
|
Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
|
K 3.1, 2.1
|
|
6ebeA
|
Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
|
K 3.1, 2.1
|
|
6edaA
|
Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
|
K 3.1, 2.1
|
|
6eeoA
|
Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
|
K 3.1, 2.1
|
|
6eehA
|
Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
|
K 3.1, 2.1
|
|
6eczA
|
Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms ix and xii and show hypoxia-enhanced cytotoxicity against human cancer cell lines.
|
K 3.1, 2.1
|
2
|
6g3qA
|
Crystal structure of human carbonic anhydrase ii in complex with the inhibitor famotidine
|
K 3.1, 2.1
|
|
5thiA
|
Crystal structure of 2-hydroxycyclohepta-2,4,6-trien-1-one bound to human carbonic anhydrase 2 l198g
|
K 3.1, 2.1
|
|
4knjA
|
Crystal structure of human carbonic anhydrase isozyme ii with 2-chloro-4-[(pyrimidin-2-ylsulfanyl)acetyl]benzenesulfonamide
|
K 3.1, 2.1
|
|
4qizA
|
Crystal structure of human carbonic anhydrase isozyme xiii with inhibitor
|
K 3.1, 2.1
|
|
1bn1A
|
Carbonic anhydrase ii inhibitor
|
K 3.1, 2.1
|
|
5n25A
|
Crystal structure of human carbonic anhydrase ii in complex with the inhibitor 4-pyridin-3-yl-benzenesulfonamide
|
K 3.1, 2.1
|
|
5ohhA
|
Crystal structure of human carbonic anhydrase isozyme xiii with 2-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-3,5,6-trifluoro-4-[(2-hydroxyethyl)thio]benzenesulfonamide
|
K 3.1, 2.1
|
|
1cakA
|
Structural analysis of the zinc hydroxide-thr 199-glu 106 hydrogen bonding network in human carbonic anhydrase ii
|
K 3.1, 2.1
|
|
1rzbA
|
X-ray analysis of metal substituted human carbonic anhydrase ii derivatives
|
K 3.1, 2.1
|
|
4qsjA
|
Crystal structure of human carbonic anhydrase isozyme xiii with 2-chloro-4-{[(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetyl}benzenesulfonamide
|
K 3.1, 2.1
|
|
1bv3A
|
Human carbonic anhydrase ii complexed with urea
|
K 3.1, 2.1
|
|
1ttmA
|
Human carbonic anhydrase ii complexed with 667-coumate
|
K 3.1, 2.1
|
|
5neaA
|
Crystal structure of human carbonic anhydrase ii in complex with the inhibitor 4-(2-methyl-1,3-oxazol-5-yl)benzene-1-sulfonammide
|
K 3.1, 2.1
|
|
5fl5A
|
Three dimensional structure of human carbonic anhydrase ix in complex with 5-(1-(4-methoxyphenyl)-1h-1,2,3-triazol-4-yl)thiophene-2- sulfonamide
|
K 3.1, 2.1
|
|
1bnnA
|
Carbonic anhydrase ii inhibitor
|
K 3.1, 2.1
|
|
4yglA
|
Naclo4--interactions between hofmeister anions and the binding pocket of a protein
|
K 3.1, 2.1
|
|
3iqkA
|
Human carbonic anhydrase ii h64a complexed with thioxolone hydrolysis products
|
K 3.1, 2.1
|
|
6b59A
|
Carbonic anhydrase ii in complex with nitrogenous base-bearing benezenesulfonamide
|
K 3.1, 2.1
|
|
3mnkA
|
Human carbonic anhydrase ii mutant k170h
|
K 3.1, 2.1
|
|
1g3zA
|
Carbonic anhydrase ii (f131v)
|
K 3.1, 2.1
|
2
|
2nnvA
|
Structure of inhibitor binding to carbonic anhydrase ii
|
K 3.1, 2.1
|
|
3dc9A
|
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
|
K 3.1, 2.1
|
|
3dazA
|
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
|
K 3.1, 2.1
|
|
2cbaA
|
Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes
|
K 3.1, 2.1
|
2
|
3s72B
|
The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase
|
K 3.1, 2.1
|
|
2cbdA
|
Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes
|
K 3.1, 2.1
|
|
3nj9A
|
Crystal structure of carbonic anhydrase ii in complex with a nir inhibitor
|
K 3.1, 2.1
|
|
4e3hA
|
Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors
|
K 3.1, 2.1
|
|
4ca2A
|
Engineering the hydrophobic pocket of carbonic anhydrase ii
|
K 3.1, 2.1
|
|
4fptA
|
Carbonic anhydrase ii in complex with ethyl (2z,4r)-2-(sulfamoylimino)-1,3-thiazolidine-4-carboxylate
|
K 3.1, 2.1
|
|
3r17B
|
Hcarbonic anhydrase ii bound to n-(2-fluoro.4-sulfamoylphenyl)-2-(thiophen-2-yl) acetamide
|
K 3.1, 2.1
|
|
4zwzA
|
Engineered carbonic anhydrase ix mimic in complex with a glucosyl sulfamate inhibitor
|
K 3.1, 2.1
|
|
4q07A
|
Crystal structure of chimeric carbonic anhydrase ix with inhibitor
|
K 3.1, 2.1
|
|
5g01A
|
An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition and protein x-ray structure of psammaplin c
|
K 3.1, 2.1
|
|
4mdlA
|
Meta carborane carbonic anhydrase inhibitor
|
K 3.1, 2.1
|
2
|
5tt3A
|
Crystal structure of the complex of helicobacter pylori alpha-carbonic anhydrase with ethoxzolamide
|
K 3.1, 2.1
|
|
5umcA
|
Synthesis of novel seleno ureido containing compounds as slc-0111 analogs. investigations on carbonic anhydrases activity, glutathione peroxidase and x-ray crystallography
|
K 3.1, 2.1
|
|
4q09A
|
Crystal structure of chimeric carbonic anhydrase xii with inhibitor
|
K 3.1, 2.1
|
|
1g46A
|
Carbonic anhydrase ii (f131v) complexed with 4-(aminosulfonyl)-n-[(2,3-difluorophenyl)methyl]-benzamide
|
K 3.1, 2.1
|
|
5ogpA
|
Metalacarborane inhibitors of carbonic anhydrase ix
|
K 3.1, 2.1
|
|
1if6A
|
Carbonic anhydrase ii complexed with 3,5-difluorobenzenesulfonamide
|
K 3.1, 2.1
|
|
6ekiA
|
Structure of a hyperthermostable carbonic anhydrase identified from an active hydrothermal vent chimney
|
K 3.1, 2.1
|
|
3igpA
|
Structure of inhibitor binding to carbonic anhydrase ii
|
K 3.1, 2.1
|
|
5fnhA
|
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination
|
K 3.1, 2.1
|
|
3w6hA
|
Crystal structure of 19f probe-labeled hcai in complex with acetazolamide
|
K 3.1, 2.1
|
|
5cluA
|
The crystal structure of the complex of hcaii with a saccharine derivative
|
K 3.1, 2.1
|
|
1i9nA
|
Carbonic anhydrase ii (f131v) complexed with 4-(aminosulfonyl)-n-[(2,5-difluorophenyl)methyl]-benzamide
|
K 3.1, 2.1
|
|
3mhcA
|
Crystal structure of human cabonic anhydrase ii in adduct with an adamantyl analogue of acetazolamide in a novel hydrophobic binding pocket
|
K 3.1, 2.1
|
|
5flsA
|
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination
|
K 3.1, 2.1
|
|
1cnjA
|
X-ray crystallographic studies of engineered hydrogen bond networks in a protein-zinc binding site
|
K 3.1, 2.1
|
|
1if4A
|
Carbonic anhydrase ii complexed with 4-fluorobenzenesulfonamide
|
K 3.1, 2.1
|
|
4pyyA
|
Crystal structure of human carbonic anhydrase isozyme ii with inhibitor
|
K 3.1, 2.1
|
|
4k0tA
|
Structure of hcaix mimic (hcaii with 5 mutations in active site) in complex with chlorzolamide
|
K 3.1, 2.1
|
|
4qsbA
|
Crystal structure of human carbonic anhydrase isozyme ii with 3-{[(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetyl}benzenesulfonamide
|
K 3.1, 2.1
|
|
4k0sA
|
Structure of hcaix mimic (hcaii with 5 mutations in active site) in complex with acetazolamide
|
K 3.1, 2.1
|
|
3mnaA
|
The crystal structure of human carbonic anhydrase ii in complex with a 1,3,5-triazine-substituted benzenesulfonamide inhibitor
|
K 3.1, 2.1
|
|
4n0xB
|
Room temperature crystal structure of human carbonic anhydrase ii in complex with thiophene-2-sulfonamide
|
K 3.1, 2.1
|
|
3mzcA
|
Human carbonic ahydrase ii in complex with a benzenesulfonamide inhibitor
|
K 3.1, 2.1
|
|
5msaA
|
Crystal structure of human carbonic anhydrase isozyme xii with 2,3,5,6-tetrafluoro-4-(propylthio)benzenesulfonamide
|
K 3.1, 2.1
|
2
|
5neeA
|
Crystal structure of human carbonic anhydrase ii in complex with the inhibitor 5-[2-(morpholine-4-carbonyl)1,3-oxazol-5-yl)]thiophene-2-sulfonammide
|
K 3.1, 2.1
|
|
2hfwA
|
Structural and kinetic analysis of proton shuttle residues in the active site of human carbonic anhydrase iii
|
K 3.1, 2.1
|
|
2f14A
|
Tne crystal structure of the human carbonic anhydrase ii in complex with a fluorescent inhibitor
|
K 3.1, 2.1
|
|
3d92A
|
Human carbonic anhydrase ii bound with substrate carbon dioxide
|